Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, December 24 through Wednesday, December 26 inclusive. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 28.06.16 in Vol 5, No 2 (2016): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5791):

(note that this is only a small subset of citations)

  1. Flamant M, Paul S, Roblin X. Golimumab for the treatment of ulcerative colitis. Expert Opinion on Biological Therapy 2017;17(7):879
    CrossRef
  2. Lopetuso L, Gerardi V, Papa V, Scaldaferri F, Rapaccini G, Gasbarrini A, Papa A. Can We Predict the Efficacy of Anti-TNF-α Agents?. International Journal of Molecular Sciences 2017;18(9):1973
    CrossRef